Strides Pharma Science Ltd 2023 Integrated Report
Company: Strides Pharma Science Ltd
Sector: Manufacturing
Country: India
Year: 2023
Type: Integrated Report
Pages: 187
The report describes a rebound in FY 2022-23, led by regulated-market growth and cost optimization, with revenue of ₹37,042 Million. It reports 2.23% in-house clean-energy generation and ongoing solar expansion. ESG governance was advanced through a Sustainability Council and reporting roadmap, while CSR initiatives focused on healthcare, education, and employability.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.